Risankizumab and Psoriatic Arthritis Risk in Psoriasis: Screening, Treatment Selection, and Real-World Data

Psoriatic arthritis often surfaces years after the skin diagnosis, making the dermatology visit a decisive checkpoint. This opening segment weighs risk markers and the structured questioning that surfaces joint disease before damage sets in.